Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Breaking News Watson Laboratories Recall 9.24.12
Share |

IACP Breaking News


Watson Issues Voluntary Nationwide Recall of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized and Superpotent Tablets

9/24/12 -- Watson Laboratories, Inc. today issued a voluntary nationwide recall for two lots of Hydrocodone Bitartrate and APAP Tablets, USP 10 mg/500 mg. A customer complaint was received for tablets that were thicker and darker shade than the other tablets. It is possible that some tablets from lots 519406A and 521759A exceed the weight specification and may contain higher than indicated amounts of the ingredients Hydrocodone Bitartrate and/or Acetaminophen.


Click here to view Watson Laboratories, Inc. press release in its entirety.

Click here to view FDA Safety Alert.



Return to IACP Home Page


Association Management Software Powered by YourMembership  ::  Legal